Myriad Genetics | MYGN - Net Income


Myriad Genetics reported $-7.9M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Danaher USD 870M 159M Jun/2026
Illumina USD 207M 73M Jun/2026
J&J USD 5.53B 299M Jun/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 320M 69M Jun/2026
Quidel USD -92.9M 1.1M Jun/2026
Repligen USD 5.01M 3.32M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Veracyte USD 25.49M 3.22M Jun/2026
Waters USD -136M 64M Jun/2026